← Eichor
Condition: Bipolar 1 Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Bipolar 1 Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulat
Phase 4 · 2 location(s) · Region Örebro County · NCT07026461Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder
NA · 1 location(s) · Centre Hospitalier St Anne · NCT07194278Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine
Phase 1/Phase 2 · 6 location(s) · Mapi Pharma Ltd. · NCT07185815A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Ep
Phase 3 · 81 location(s) · AbbVie · NCT04777357Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Phase N/A · 3 location(s) · Forschungsinstitut der Diabetes Akademie Mergentheim · NCT07212075Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
NA · 1 location(s) · Mclean Hospital · NCT06221852A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed
Phase 1/Phase 2 · 1 location(s) · Alzamend Neuro, Inc. · NCT07540338A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipola
Phase 3 · 28 location(s) · Xenon Pharmaceuticals Inc. · NCT07172516An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Ma
Phase 2 · 6 location(s) · Neurocrine Biosciences · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2
Phase 3 · 85 location(s) · Bristol-Myers Squibb · NCT06951711Evaluation of Efficiency of One Day Patient/Caregiver Psychoeducation on the Caregiver's Burden
NA · 1 location(s) · University Hospital, Montpellier · NCT05178966A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · 73 location(s) · Bristol-Myers Squibb · NCT06951698Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · 47 location(s) · Alkermes, Inc. · NCT05303064A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · 33 location(s) · AbbVie · NCT06696755Children's Bipolar Network Treatment Trial I
Phase N/A · 4 location(s) · University of California, Los Angeles · NCT05427123Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
NA · 1 location(s) · VA Office of Research and Development · NCT05157620NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
Phase 2 · 1 location(s) · China Medical University Hospital · NCT05977023Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Phase 2 · 26 location(s) · LB Pharmaceuticals Inc. · NCT07494305A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · 174 location(s) · Bristol-Myers Squibb · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · 104 location(s) · Bristol-Myers Squibb · NCT07140913LHC-CIDI-5 in Hong Kong
Phase N/A · 1 location(s) · The University of Hong Kong · NCT06804525Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT05064319Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
NA · 3 location(s) · Stony Brook University · NCT06373016Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
Phase 2 · 1 location(s) · Mclean Hospital · NCT05837104Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Phase 4 · 9 location(s) · Vanda Pharmaceuticals · NCT05648591SYNCED - SYNChronized Eating in Bipolar Depression Study
NA · 1 location(s) · University of Ottawa · NCT06560957Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · 22 location(s) · Rapport Therapeutics Inc. · NCT07046494CLOZAPINE Response in Biotype-1
Phase 4 · 5 location(s) · University of Texas Southwestern Medical Center · NCT04580134
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.